Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment

Acta Ophthalmologica

Volumn 88, Issue 3, 2010, Pages

  Kontkanen, Matti ^a   Paimela, Leena ^b   Kaarniranta, Kai ^c,d  

^a NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^b ORTON Invalid Foundation   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; INFLIXIMAB; METHOTREXATE; PREDNISOLONE;

ADULT; ANTERIOR EYE CHAMBER; BLINDNESS; CASE REPORT; DRUG DOSE REDUCTION; EVENING DOSAGE; EYE EXAMINATION; FOLLOW UP; HUMAN; INFLAMMATORY CELL; LETTER; MAINTENANCE THERAPY; MALE; NECROTIZING SCLERITIS; PRIORITY JOURNAL; REMISSION; SCLERITIS; SLIT LAMP; VISUAL ACUITY; WEGENER GRANULOMATOSIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; HUMANS; MALE; SCLERITIS; TUMOR NECROSIS FACTOR-ALPHA; VISUAL ACUITY; WEGENER GRANULOMATOSIS;

EID: 77951764569     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01546.x     Document Type: Letter

References (5)

1. Bartolucci P, Ramanoelina J Cohen P (2002 Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford) 41 : 1126 1132.
2. Foster CS Vitale AT (2004 Immunosuppressive chemotherapy. In : Watson PG, Hazleman B, Pavesio C Green WR (eds). The sclera and systemic disorders.
3. Pakrou N, Selva D Leibovitch I (2006 Wegener's granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum 35 : 284 292.
4. Sahlin S, Lignell B, Williams M, Dastmalchi M Orego A (2008 Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab. Acta Ophthalmol [Epub ahead of print].
5. Soukiasian SH, Foster CS, Niles JL Raizman MB (1992 Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis. Ophthalmology 99 : 125 132.